Abstract
Cefotetan (CTT, YM09330), a new cephamycin antibiotic, was applied to 11 patients including 4 cases of respiratory tract infections, 6 cases of urinary tract infections and one case of orchitis. A daily dose of 0.5 to 2.0g was injected intravenously or drip infused for 5 to 12 days. The clinical results were good in all cases, and there were no side effect which might be directly associated with the drug.
Cefotetan seems to be useful for respiratory and urinary tract infections like other cephamycin derivatives.
